COVID-19患者脑电图异常常见且与不良结局相关
这项多中心回顾性队列研究纳入197例因临床指征接受连续脑电图监测的COVID-19患者,发现9.6%存在电graphic癫痫发作,48.7%有癫痫样异常。电graphic癫痫发作是院内死亡的独立预测因素(HR 4.07),NCSE与住院时间延长相关。
要点
- COVID-19患者cEEG监测中电graphic癫痫发作率9.6%,NCSE 5.6%
- 既往临床癫痫发作与电graphic癫痫发作和NCSE独立相关
- 电graphic癫痫发作是院内死亡的独立预测因素(HR 4.07)
核心结论
- 在因临床指征接受cEEG的COVID-19患者中,癫痫发作和其他癫痫样异常常见,且与不良临床结局相关。
研究设计与样本
- 多中心回顾性队列研究,纳入9个中心197例因临床指征转诊cEEG的COVID-19患者,回顾病历和EEG报告,采用多因素Cox比例风险分析评估EEG模式与临床结局的关系。
主要发现
- 电graphic癫痫发作检出19例(9.6%),其中非惊厥性癫痫持续状态(NCSE)11例(5.6%)。
- 癫痫样异常(发作期或发作间期)存在于96例(48.7%)。
- 住院期间既往临床癫痫发作与电graphic癫痫发作相关(有既往临床发作36.4% vs 无8.1%,OR 6.51,p=0.01)及NCSE相关(27.3% vs 4.3%,OR 8.34,p=0.01)。
- 神经影像学上既存颅内病灶与NCSE相关(14.3% vs 3.7%;OR 4.33,p=0.02)。
- 多因素分析中,电graphic癫痫发作是院内死亡的独立预测因素(HR 4.07 [1.44-11.51],p<0.01)。
临床怎么用
- 对COVID-19患者,尤其有既往临床癫痫发作或神经影像学颅内病灶者,应考虑cEEG监测以检出电graphic癫痫发作和NCSE。
- 电graphic癫痫发作提示院内死亡风险增高,需加强监测和干预。
局限性
- 回顾性研究设计,仅纳入因临床指征接受cEEG的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim was to determine the prevalence and risk factors for electrographic seizures and other electroencephalographic (EEG) patterns in patients with Coronavirus disease 2019 (COVID-19) undergoing clinically indicated continuous electroencephalogram (cEEG) monitoring and to assess whether EEG findings are associated with outcomes. METHODS: We identified 197 patients with COVID-19 referred for cEEG at 9 participating centers. Medical records and EEG reports were reviewed retrospectively to determine the incidence of and clinical risk factors for seizures and other epileptiform patterns. Multivariate Cox proportional hazards analysis assessed the relationship between EEG patterns and clinical outcomes. RESULTS: Electrographic seizures were detected in 19 (9.6%) patients, including nonconvulsive status epilepticus (NCSE) in 11 (5.6%). Epileptiform abnormalities (either ictal or interictal) were present in 96 (48.7%). Preceding clinical seizures during hospitalization were associated with both electrographic seizures (36.4% in those with vs 8.1% in those without prior clinical seizures, odds ratio [OR] 6.51, p = 0.01) and NCSE (27.3% vs 4.3%, OR 8.34, p = 0.01). A pre-existing intracranial lesion on neuroimaging was associated with NCSE (14.3% vs 3.7%; OR 4.33, p = 0.02). In multivariate analysis of outcomes, electrographic seizures were an independent predictor of in-hospital mortality (hazard ratio [HR] 4.07 [1.44-11.51], p < 0.01). In competing risks analysis, hospital length of stay increased in the presence of NCSE (30 day proportion discharged with vs without NCSE: HR 0.21 [0.03-0.33] vs 0.43 [0.36-0.49]). INTERPRETATION: This multicenter retrospective cohort study demonstrates that seizures and other epileptiform abnormalities are common in patients with COVID-19 undergoing clinically indicated cEEG and are associated with adverse clinical outcomes. ANN NEUROL 2021;89:872-883.
引用
- Lin L, Al-Faraj A, Ayub N, et al. Electroencephalographic Abnormalities are Common in COVID-19 and are Associated with Outcomes. Ann Neurol. 2021. PMID: 33704826. doi:10.1002/ana.26060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。